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THE EVALUATION OF CANCER CONTROL MEASURES
SUMMARY OF THE CONCLUSION OF UICC SYMPOSIUM HELD IN SHEFFIELD
IN SEPTEMBER 1972
Prepared by D. A. BOYES, r. KNOWELDEN AND A. J. PHILLIPS (Chairinan)
Committee on Cancer Prevention and Detection, Internationzal Union Against Cancer
Summary.-The assessment of a screening procedure falls into two parts. The
first is the development of a test and the establishment of criteria of specificity and
sensitivity. The second stage is that of the application of the test to the general
population, demanding attention to the natural history of the disease and to the
usefulness and simplicity of the test itself. The decision to organize a screening
programme has usually to be taken on the basis of incomplete information and in the
setting of a population subjected to constant change. It is the hope of the Committee
on Cancer Prevention and Detection of the UICC that the conclusions from the Sym-
posium will prove helpful to all who face such decisions.
THE hypothesis that early detection
reduces the chance of invasive cancer has
been widely accepted and has resulted in
a variety of mass screening programmes
for specific sites of the disease. However,
increasing scepticism of the effectiveness
of such measures has been expressed,
ranging from reasonable certaintv that
some measures such as radiography for
lung cancer are not (and are not likely to
be) effective, to the problems which arise
when a procedure is shown to be imple-
mented only at great cost, as in proposals
for breast cancer screening.
These doubts have been reinforced
because for some sites, screening pro-
grammes have been followed by reductions
in incidence rates but not by similar
changes in mortality. Furthermore, there
may be uncertaintv about the effect of a
screening test because too little is known
about the natural history of the disease.
In cancer of the cervix, for example,
cytological examinations reveal the pre-
sence of carcinoma in situ, but the dura-
tion of this lesion and the frequency with
which it becomes invasive are not reliably
established; without this information it is
impossible to predict the value of excision
in the pre-symptomatic stage. It is also
essential to refine a screening test in order
that it may have high specificity, as
measured by a low proportion of false
" positive " results, and high sensitivity,
as measured by a low proportion of false
" negative " results.
Finally, there is uncertainty about the
best way ofapplying a screening procedure
for maximum effect, whether to a total
population or to a selected group most at
risk. Ifthe latter is adopted there may be
difficulties in defining this " at risk
group and practical problems of ensuring
that these persons are adequately
screened.
Recognizing the need for careful study
and assessment of mass screening pro-
grammes, the Committee on Cancer Pre-
vention and Detection ofthe International
Union Against Cancer (UICC) convened a
symposium in September 1972, to evaluate
their effectiveness. This is a brief report
of the conclusions reached by some 27
participants, from 8 different countries,
each of whom was directly involved in
some aspect of a screening programme.
A complete report of the symposium will
be published later by the UICC.
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The symposium reached a consensus
view on the value of screening for lesions
of the cervix, breast and stomach. It
agreed that screening tests for other sites
were not yet ready for application, either
because results were not clear-cut or
because no effective treatment was avail-
able for the condition detected.
A. Screening for cancer of the cervix
The symposium reviewed the cervical
screening programmes in British Columbia
(Canada), Jefferson County (Kentucky,
U.S.A.) and the North-east Region of
Scotland. In British Columbia 80% of
the 690,000 women over 20 years of age
have been screened. The incidence of
clinical invasive carcinoma of the cervix
has declined from 28 4 to 10 7 per 100,000
population and the mortality has declined
significantly between 1958 and 1971. In
Jefferson County the population over 20
years of age is approximately 210,000 and
since 1956 over 90%o have been screened;
the incidence of invasive squamous carci-
noma has decreased from 44-9 to 29.7 per
100,000 population and the decrease in
mortalitv is significant, although not
significant for the state of Kentucky as a
whole. In North-east Scotland 85o% of
the 125,000 married women of all ages
have been screened; the incidence of
clinical cases has decreased from 26 cases
in 1968 to 10 cases in 1971. The Sympo-
sium recognized the difficulty of assessing
how much organized screening pro-
grammes had contributed to these changes
in incidence and mortality.
In addition to the statistical results
from organized screening programmes,
consideration was given to such practical
factors as the effects ofimmigration, errors
in diagnosis, differences between labora-
tories in setting the dividing line between
pathological states, differences in labora-
tory standards, effects of an educational
programme and changes in the social
characteristics of high risk groups.
At the conclusion of this session, there
was unanimous agreement that (1) ex-
foliative cytology of the cervix provides a
test of value both in gynaecological
diagnosis and in screening apparently
healthy women, and that a laboratory
facility, under a trained cytologist, should
be supplied wherever consultative medi-
cine is available; (2) the use of this test as
a population screening procedure promises
useful yields of pre-invasive or early
cancer and potential reduction in mor-
tality. However, to realize this potential
and to achieve substantial control of
cervical cancer mortality there must be a
well organized service backed by a research
and development effort, so that progress
can be measured and the service adapted
to the needs and circumstances of the
particular population.
B. Screeningfor cancer of the breast
The only large-scale controlled popula-
tion screening project that has been
reported on is that ofthe Health Insurance
Plan of Greater New York (HIP), organ-
ized in 1963 to determine whether or not
repetitive breast cancer screening with
mammography and clinical examination
would result in a reduction in mortality
from breast cancer in the female popula-
tion. Women aged 40-64 years were
randomly allocated to 2 groups, the
study group to be screened annually and
the control group to use the ordinarv
medical care facilities. In the first 5
years of follow-up those in the studv
group showed a substantiallv lower mor-
tality from breast cancer (40 cases) than
those in the control group (63 cases)
although this reduction was found at ages
50 and over but not at ages 40-49 years.
Mortalitv from all causes, other than
breast cancer, was almost identical for the
two groups.
The delegates discussed various factors
which might have affected the outcome of
this study; for example, the probability
that screening by mammography detected
tumours of low malignanev with a corres-
ponding slow growth rate, the possibility
that the lead time of one year for cases
detected by screening, allowed for in the
comparison, might have been too short,
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and the possibility that the history of the
tumours differed between the study and
control groups. At the end of the dis-
cussioni it was agreed that the evidence
supported the conclusion that massscreen-
ing for breast cancer had saved lives but
that it was so demanding of medical
resources of all kinds as to require further
study, including cost benefit, to determine
whether it was applicable in particular
populations.
C. Screening for cancer of the gastro-
intestinal tract and liver
The experience presented at the sym-
posium included the early detection of
cancer of the stomach in Japan, the
carcino-embryonic antigen (CEA) test for
cancer of the colon and rectum, and the
alpha-foetoprotein test for early detection
of primary liver cancer. The data pre-
sented from Japan showed that the
incidence and mortality from cancer ofthe
stomach were as much as 6 times higher
than in some other countries, and that
there had been a significant decline in the
mortality in the areas of the country
where mass screening had been organ-
ized.
The joint National Cancer Institute of
Canada/American Cancer Society investi-
gation of the CEA test had shown it to be
unsuitable as yet as a mass screening
procedure; the reproducibility of the test
between local laboratories and the refer-
ence laboratory, aind its sensitivity anid(
specificity had all been questioned in the
trial. The test was considered ofpotential
value as an aid in establishing thediagnosis
of colo-rectal cancer but, as a screening
procedure for cancer in asymptomatic
patients, it remained to be assessed in
large-scale studies.
The alpha-foetoprotein test for liver
cancer was studied in 7 centres and was
found to be an excellent tool for diag-
nosing primary liver cancer. It was
shown to be reproducible, highly specific
and fairly sensitive. It could be used for
mass screening as it was possible to
organize population surveys and detect
cases of primary liver cancer including
some at a pre-symptomatic stage. How-
ever, it had not been possible to show
measurable improvement in the health
status of the patients detected, so it could
not be recommended in the form in which
it was investigated.
In the realm ofgastrointestinal cancer,
there was agreement in the symposium
that screening for cancer of the stomach,
as organized in Japan, had a significant
effect on mortality and morbidity, but
that the carcino-embryonic antigen test
and the alpha-foetoprotein test in their
present forms could not be recommended.
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